1076400

Brimonidine tartrate

United States Pharmacopeia (USP) Reference Standard

• Formule empirique (notation de Hill) : C₁₅H₁₆BrN₅O₆
• Numéro CAS: 70359-46-5
• Poids moléculaire : 442.22
• MDL number: MFCD07773072
• UNSPSC Code: 41116107
• NACRES: NA.24

Propriétés

• grade: pharmaceutical primary standard
• agency: USP
• API family: brimonidine
• form: powder
• manufacturer/tradename: USP
• application(s): pharmaceutical (small molecule)
• format: neat
• SMILES string: Brc1c2nccnc2ccc1NC3=NCCN3.O[C@H]([C@@H](O)C(=O)O)C(=O)O
• InChI: 1S/C11H10BrN5.C4H6O6/c12-9-7(17-11-15-5-6-16-11)1-2-8-10(9)14-4-3-13-8;5-1(3(7)8)2(6)4(9)10/h1-4H,5-6H2,(H2,15,16,17);1-2,5-6H,(H,7,8)(H,9,10)/t;1-,2-/m.1/s1
• InChI key: QZHBYNSSDLTCRG-LREBCSMRSA-N

Description

General description

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

Application

Brimonidine tartrate USP reference standard for use in specified quality tests and assays.

Also used to prepare standard, system suitability, and sensitivity solutions during the assay, and impurity analysis of brimonidine tartrate.

Analysis Note

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.  ​

Other Notes

Sales restrictions may apply.

Informations sur la sécurité

• pictograms: GHS06
• signalword: Danger
• hcodes: H301,H315,H319,H335
• pcodes: P301 + P310 + P330 - P302 + P352 - P305 + P351 + P338
• Hazard Classifications: Acute Tox. 3 Oral - Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3
• target_organs: Respiratory system
• Classe de stockage: 6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects
• wgk: WGK 3